Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Fraser

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Emerging Infectious Diseases|November 12, 2003
Superantigens and streptococcal toxic shock syndromeThomas Proft, Shiranee Sriskandan, Lily Yang, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|April 29, 2005
Piezoelectric micromachined ultrasonic transducers: modeling the influence of structural parameters on device performanceFiras Akasheh, John D Fraser, Susmita Bose, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 2, 2018
Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysisYan Li, Fiona Clow, John D Fraser, et al.
Immunology and Cell Biology|June 26, 2013
Full functional activity of SSL7 requires binding of both complement C5 and IgANatalie Lorenz, Fiona Clow, Fiona J Radcliff, et al.
Expert Review of Vaccines|November 13, 2015
Development of Group A streptococcal vaccines: an unmet global health needMeru Sheel, Nicole J Moreland, John D Fraser, et al.
Infection and Immunity|February 22, 2003
Two novel superantigens found in both group A and group C StreptococcusThomas Proft, Phillip D Webb, Vanessa Handley, et al.
The Indian Journal of Medical Research|July 3, 2004
Identification & characterisation of the two novel streptococcal pyrogenic exotoxins SPE-L & SPE-MProft Thomas, Phillip D Webb, Vanessa Handley, et al.
The Journal of Biological Chemistry|November 19, 2005
A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgABruce D Wines, Natasha Willoughby, John D Fraser, et al.
American Journal of Rhinology & Allergy|May 31, 2012
Staphylococcus aureus. Letters to the editorAndrew J Wood, John D Fraser, Satya Amirapu, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 1, 2006
The impact of the research methods support structure on research capacity in rural New South WalesJohn D Fraser, Antonia Hawkins, Christian Alexander, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Emerging Infectious Diseases|November 12, 2003
Superantigens and streptococcal toxic shock syndromeThomas Proft, Shiranee Sriskandan, Lily Yang, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|April 29, 2005
Piezoelectric micromachined ultrasonic transducers: modeling the influence of structural parameters on device performanceFiras Akasheh, John D Fraser, Susmita Bose, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 2, 2018
Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysisYan Li, Fiona Clow, John D Fraser, et al.
Immunology and Cell Biology|June 26, 2013
Full functional activity of SSL7 requires binding of both complement C5 and IgANatalie Lorenz, Fiona Clow, Fiona J Radcliff, et al.
Expert Review of Vaccines|November 13, 2015
Development of Group A streptococcal vaccines: an unmet global health needMeru Sheel, Nicole J Moreland, John D Fraser, et al.
Infection and Immunity|February 22, 2003
Two novel superantigens found in both group A and group C StreptococcusThomas Proft, Phillip D Webb, Vanessa Handley, et al.
The Indian Journal of Medical Research|July 3, 2004
Identification & characterisation of the two novel streptococcal pyrogenic exotoxins SPE-L & SPE-MProft Thomas, Phillip D Webb, Vanessa Handley, et al.
The Journal of Biological Chemistry|November 19, 2005
A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgABruce D Wines, Natasha Willoughby, John D Fraser, et al.
American Journal of Rhinology & Allergy|May 31, 2012
Staphylococcus aureus. Letters to the editorAndrew J Wood, John D Fraser, Satya Amirapu, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 1, 2006
The impact of the research methods support structure on research capacity in rural New South WalesJohn D Fraser, Antonia Hawkins, Christian Alexander, et al.
Pageof 8